There are 2949 resources available
1558P - Pancreatic cancer (PC) in patients (pts) younger than 50 years: Clinical outcomes and actionable genomic/genetic alterations
Presenter: Alejandro Garcia-Alvarez
Session: E-Poster Display
Resources:
Abstract
1559P - Chemotherapy related changes of peripheral blood lymphocytes in advanced and metastatic PDAC
Presenter: Skaiste Tulyte
Session: E-Poster Display
Resources:
Abstract
1560P - Sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT): Prevalence and clinical implications
Presenter: Ilaria Trestini
Session: E-Poster Display
Resources:
Abstract
1561P - Anemia and iron deficiency (ID) in association with tissue iron regulators - Hepcidin, ferroportin and ZIP14 expression in patients with pancreatic cancer (PC)
Presenter: Malgorzata Osmola
Session: E-Poster Display
Resources:
Abstract
1562P - Observational prospective study of Italian guidelines application for patients with pancreatic ductal adenocarcinoma
Presenter: Michele Reni
Session: E-Poster Display
Resources:
Abstract
1563P - Early clinical trials in patients with pancreatic cancer: Assessment of factors limiting eligibility and effectiveness
Presenter: Fouad Kerbage
Session: E-Poster Display
Resources:
Abstract
1564P - Clinical pathway implications and real-world characteristics and outcomes for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with first line category 1 National Comprehensive Cancer Network (NCCN) regimens
Presenter: George Kim
Session: E-Poster Display
Resources:
Abstract
1565P - Clinical outcome after perioperative treatment on locally advanced and borderline pancreatic cancer: Experience of a single academic center
Presenter: Susana Roselló Keränen
Session: E-Poster Display
Resources:
Abstract
1566TiP - PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma
Presenter: Christelle de la Fouchardiere
Session: E-Poster Display
Resources:
Abstract
1567TiP - A phase III trial of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC): PANOVA-3
Presenter: Vincent J. Picozzi
Session: E-Poster Display
Resources:
Abstract